vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and V F CORP (VFC). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $2.9B, roughly 1.9× V F CORP). V F CORP runs the higher net margin — 10.5% vs 7.9%, a 2.5% gap on every dollar of revenue. On growth, V F CORP posted the faster year-over-year revenue change (1.5% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
The F. W. Woolworth Company was a retail company and one of the pioneers of the five-and-dime store. It was among the most successful American and international five-and-dime businesses, setting trends and creating the modern retail model that stores worldwide follow today.
FMS vs VFC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $2.9B |
| Net Profit | $434.2M | $300.8M |
| Gross Margin | 27.4% | 56.6% |
| Operating Margin | 11.7% | 10.1% |
| Net Margin | 7.9% | 10.5% |
| Revenue YoY | -0.3% | 1.5% |
| Net Profit YoY | 240.4% | 79.3% |
| EPS (diluted) | — | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $2.9B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $5.5B | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | $434.2M | $300.8M | ||
| Q3 25 | — | $189.8M | ||
| Q2 25 | — | $-116.4M | ||
| Q1 25 | — | $-150.8M | ||
| Q4 24 | $127.6M | $167.8M | ||
| Q3 24 | — | $52.2M | ||
| Q2 24 | — | $-258.9M | ||
| Q1 24 | — | $-418.3M |
| Q4 25 | 27.4% | 56.6% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 53.9% | ||
| Q1 25 | — | 52.7% | ||
| Q4 24 | 25.0% | 56.3% | ||
| Q3 24 | — | 52.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | 48.4% |
| Q4 25 | 11.7% | 10.1% | ||
| Q3 25 | — | 11.2% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 5.1% | 8.0% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | -12.6% | ||
| Q1 24 | — | -15.0% |
| Q4 25 | 7.9% | 10.5% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | -6.6% | ||
| Q1 25 | — | -7.5% | ||
| Q4 24 | 2.3% | 5.9% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -17.6% |
| Q4 25 | — | $0.76 | ||
| Q3 25 | — | $0.48 | ||
| Q2 25 | — | $-0.30 | ||
| Q1 25 | — | $-0.37 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | — | $0.13 | ||
| Q2 24 | — | $-0.67 | ||
| Q1 24 | — | $-1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $1.5B |
| Total DebtLower is stronger | — | $3.6B |
| Stockholders' EquityBook value | $15.4B | $1.8B |
| Total Assets | $33.5B | $10.4B |
| Debt / EquityLower = less leverage | — | 1.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | — | $419.1M | ||
| Q2 25 | — | $642.4M | ||
| Q1 25 | — | $429.4M | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | — | $492.2M | ||
| Q2 24 | — | $637.4M | ||
| Q1 24 | — | $674.6M |
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.6B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | — | $3.9B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $4.7B |
| Q4 25 | $15.4B | $1.8B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $17.0B | $1.7B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | $33.5B | $10.4B | ||
| Q3 25 | — | $10.6B | ||
| Q2 25 | — | $10.2B | ||
| Q1 25 | — | $9.4B | ||
| Q4 24 | $36.3B | $10.6B | ||
| Q3 24 | — | $12.2B | ||
| Q2 24 | — | $11.5B | ||
| Q1 24 | — | $11.6B |
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.76× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 2.86× | ||
| Q2 24 | — | 2.84× | ||
| Q1 24 | — | 2.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $1.0B |
| Free Cash FlowOCF − Capex | — | $977.9M |
| FCF MarginFCF / Revenue | — | 34.0% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | 6.67× | 3.36× |
| TTM Free Cash FlowTrailing 4 quarters | — | $357.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $1.0B | ||
| Q3 25 | — | $-227.0M | ||
| Q2 25 | — | $-145.5M | ||
| Q1 25 | — | $-171.1M | ||
| Q4 24 | $2.6B | $918.1M | ||
| Q3 24 | — | $-301.6M | ||
| Q2 24 | — | $19.8M | ||
| Q1 24 | — | — |
| Q4 25 | — | $977.9M | ||
| Q3 25 | — | $-253.5M | ||
| Q2 25 | — | $-173.7M | ||
| Q1 25 | — | $-193.0M | ||
| Q4 24 | — | $899.7M | ||
| Q3 24 | — | $-322.4M | ||
| Q2 24 | — | $-5.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | -9.0% | ||
| Q2 25 | — | -9.9% | ||
| Q1 25 | — | -9.6% | ||
| Q4 24 | — | 31.7% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
| Q4 25 | 6.67× | 3.36× | ||
| Q3 25 | — | -1.20× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.20× | 5.47× | ||
| Q3 24 | — | -5.78× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
VFC
| Outdoor | $1.9B | 67% |
| Sales Channel Through Intermediary | $813.4M | 28% |
| Other | $136.3M | 5% |
